Haiying Chen

6.5k total citations · 2 hit papers
129 papers, 4.8k citations indexed

About

Haiying Chen is a scholar working on Molecular Biology, Oncology and Epidemiology. According to data from OpenAlex, Haiying Chen has authored 129 papers receiving a total of 4.8k indexed citations (citations by other indexed papers that have themselves been cited), including 87 papers in Molecular Biology, 19 papers in Oncology and 15 papers in Epidemiology. Recurrent topics in Haiying Chen's work include Protein Degradation and Inhibitors (15 papers), Receptor Mechanisms and Signaling (10 papers) and Chemical Synthesis and Analysis (8 papers). Haiying Chen is often cited by papers focused on Protein Degradation and Inhibitors (15 papers), Receptor Mechanisms and Signaling (10 papers) and Chemical Synthesis and Analysis (8 papers). Haiying Chen collaborates with scholars based in United States, China and Spain. Haiying Chen's co-authors include Jia Zhou, Na Ye, Eric A. Wold, Zhiqing Liu, Margarita Souleimanova, Sarkis Meterissian, Morag Park, Michael Hallett, Nicholas Bertos and Atilla Ömeroğlu and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Investigation and Nature Medicine.

In The Last Decade

Haiying Chen

120 papers receiving 4.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Stromal gene expression predicts clinical outcome in breast cancer

2008 1.3k citations Haiying Chen et al. profile →
Therapeutic Potential of Spirooxindoles as Antiviral Agents

2016 412 citations Na Ye, Haiying Chen et al. profile →

Peers

Countries citing papers authored by Haiying Chen

Since Specialization

Citations

This map shows the geographic impact of Haiying Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Haiying Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Haiying Chen more than expected).

Fields of papers citing papers by Haiying Chen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Haiying Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Haiying Chen. The network helps show where Haiying Chen may publish in the future.

Co-authorship network of co-authors of Haiying Chen

This figure shows the co-authorship network connecting the top 25 collaborators of Haiying Chen. A scholar is included among the top collaborators of Haiying Chen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Haiying Chen. Haiying Chen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	YX0798 is a highly potent, selective, and orally effective CDK9 inhibitor for treating aggressive lymphoma 2025 ·Blood Advances ·Changying Jiang, (unknown), (unknown), Qingsong Cai, (unknown), (unknown), (unknown), Yang Liu, Haiying Chen, Jia Zhou, Michael Wang	0
2	Orally Bioavailable BRD4 BD1 Inhibitor ZL0516 Effectively Suppresses Colonic Inflammation in Animal Models of Inflammatory Bowel Disease 2025 ·ACS Pharmacology & Translational Science ·Zonghui Ma, (unknown), Zhiqing Liu, Cun Zhang, Haiying Chen, Jing He, Wenjing Yang, Ronaldo P. Panganiban, Yingzi Cong, Gregory S. Yochum, Allan R. Brasier, Irina V. Pinchuk, Bing Tian, Jia Zhou	3
3	Deubiquitinase-Targeting Chimeras (DUBTACs) as a Potential Paradigm-Shifting Drug Discovery Approach 2025 ·Journal of Medicinal Chemistry ·Zonghui Ma, (unknown), Haiying Chen, Qiang Shen, Jia Zhou	7
4	5’tiRNA-Pro-TGG, a novel tRNA halve, promotes oncogenesis in sessile serrated lesions and serrated pathway of colorectal cancer 2023 ·World Journal of Gastrointestinal Oncology ·Xinyuan Wang, Yujie Zhou, Haiying Chen, (unknown), Shanshan Chen, Huimin Chen, Zheng‐Xiang Li	10
5	Scaffold repurposing of fendiline: Identification of potent KRAS plasma membrane localization inhibitors 2021 ·European Journal of Medicinal Chemistry ·Pingyuan Wang, Dharini van der Hoeven, Na Ye, Haiying Chen, Zhiqing Liu, Xiaoping Ma, Dina Montufar‐Solis, (unknown), Kwang‐Jin Cho, (unknown), Wei Chen, Ransome van der Hoeven, Jeffrey A. Frost, John F. Hancock, Jia Zhou	8
6	Further lead optimization on Bax activators: Design, synthesis and pharmacological evaluation of 2-fluoro-fluorene derivatives for the treatment of breast cancer 2021 ·European Journal of Medicinal Chemistry ·Gang Liu, Hye‐Jin Kim, Pingyuan Wang, (unknown), Haiying Chen, Tianzhi Wang, Qiang Shen, Jia Zhou	8
7	Discovery of a Small Molecule Inhibitor of Human Adenovirus Capable of Preventing Escape from the Endosome 2021 ·International Journal of Molecular Sciences ·Jimin Xu, Judith Berastegui‐Cabrera, Marta Carretero-Ledesma, Haiying Chen, Yu Xue, Eric A. Wold, Jerónimo Pachón, Jia Zhou, Javier Sánchez‐Céspedes	7
8	Discovery of phenanthridine analogues as novel chemical probes disrupting the binding of DNA to ΔFosB homodimers and ΔFosB/JunD heterodimers 2020 ·Bioorganic & Medicinal Chemistry Letters ·Yi Li, Zhiqing Liu, Galina V. Aglyamova, Jianping Chen, Haiying Chen, (unknown), Mark A. White, (unknown), Jia Zhou	4
9	Structure-activity relationship studies on Bax activator SMBA1 for the treatment of ER-positive and triple-negative breast cancer 2019 ·European Journal of Medicinal Chemistry ·Gang Liu, Tao Yin, Hyejin Kim, Chunyong Ding, Zhuo Yu, Hong Zhang, Haiying Chen, Ruping Yan, Eric A. Wold, Hao Zou, (unknown), Ye Ding, Qiang Shen, Jia Zhou	14
10	Discovery of novel mifepristone derivatives via suppressing KLF5 expression for the treatment of triple-negative breast cancer 2018 ·European Journal of Medicinal Chemistry ·Yuqi Lin, Rong Liu, Ping Zhao, Jinxiang Ye, Zheng Zheng, (unknown), Yingying Zhang, Yu Gao, Haiying Chen, (unknown), Suling Liu, Jia Zhou, Ceshi Chen, Haijun Chen	14
11	Antifibrosis Effect of Novel Oridonin Analog CYD0618 Via Suppression of the NF-κB Pathway 2018 ·Journal of Surgical Research ·Claire B. Cummins, Xiaofu Wang, Jimin Xu, Byron D. Hughes, Ye Ding, Haiying Chen, Jia Zhou, Ravi S. Radhakrishnan	14
12	Identification of peptidomimetics as novel chemical probes modulating fibroblast growth factor 14 (FGF14) and voltage-gated sodium channel 1.6 (Nav1.6) protein-protein interactions 2018 ·Bioorganic & Medicinal Chemistry Letters ·Zhiqing Liu, (unknown), A.K. Singh, Haiying Chen, Pingyuan Wang, Oluwarotimi Folorunso, Pietro Scaduto, Syed R. Ali, Fernanda Laezza, Jia Zhou	9
13	A new oridonin analog suppresses triple-negative breast cancer cells and tumor growth via the induction of death receptor 5 2016 ·Cancer Letters ·Jing Wu, Ye Ding, (unknown), (unknown), Zhongmei Zhou, Chunyong Ding, Haiying Chen, Jia Zhou, Ceshi Chen	51
14	Gene expression profiling of common signal transduction pathways affected by rBMSCs/F92A-Cav1 in the lungs of rat with pulmonary arterial hypertension 2016 ·Biomedicine & Pharmacotherapy ·Haiying Chen, Hongli Yang, Chong Xu, (unknown), Peng Xia, Pádraig Strappe, Lei Wang, Pan Li, Wenqiang Tang, Shuangfeng Chen, Lexin Wang	5
15	Visual Acuity and Self‐Reported Visual Function among Migrant Farmworkers 2016 ·Optometry and Vision Science ·Sara A. Quandt, Mark R. Schulz, Haiying Chen, Thomas A. Arcury	3
16	Expression and biological role of cytoglobin in human ovarian cancer 2014 ·Tumor Biology ·Haiying Chen, Xia Zhao, Tao Meng	15
17	Comparison between confocal laser endomicroscopy and gastric biopsy for diagnosis of early gastric cancer and precancerous disease 2012 ·Zhonghua xiaohua neijing zazhi ·(unknown), Hanbing Xue, (unknown), Xiaobo Li, Jun Dai, Xiaoyu Chen, Yun–Jie Gao, Zhi‐Zheng Ge, Haiying Chen	1
18	The protective effect of 17β-estradiol against hydrogen peroxide-induced apoptosis on mesenchymal stem cell 2012 ·Biomedicine & Pharmacotherapy ·Haiying Chen, Xian Zhang, Shuangfeng Chen, Yingxin Zhang, Yihua Liu, (unknown), Lexin Wang	33
19	Antibacterial activity and mechanism of Paenibacillus polymyxa CP7 against Peronophythora litchi. 2010 ·Acta Horticulturae Sinica ·Haiying Chen, (unknown), (unknown), (unknown)	1
20	Clinical features and risk factors of patients with fatty liver in Guangzhou area 2004 ·World Journal of Gastroenterology ·Qi‐Kui Chen, Haiying Chen, Kai-hong Huang, (unknown), (unknown), Zhaohua Zhu, (unknown)	17

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact